Effect of biological behavior and clinical significance of maspin gene on cervical squamous carcinoma SiHa cell

Objective: This study was performed to evaluate the effect of mammary serine protease inhibitor (maspin) overexpression on human cervical squamous carcinoma (SCC) SiHa cell proliferation and apoptosis in vitro. Materials and Methods: Recombinant plasmid pcDNA3-maspin was stably transfected into human cervical SCC SiHa cell. Maspin mRNA was determined by RT-PCR, whereas maspin protein was detected by Western blot analysis and immunocytochemistry (IHC). Cell proliferation activity was measured by MTT method. Apoptosis rate and cell cycle distribution were detected by flow cytometry to understand the changes in the cell biological characteristics. Results: The strengthened expression of the maspin gene in the SiHa cell was confirmed by RT-PCR, Western blot, and immunocytochemistry (IHC) (p < 0.05). Suppressed proliferation activity and increased apoptosis rate of SiHa-m (maspin stable transfected) versus SiHa and SiHa-vector cell (SiHa-pc3) were shown by MTT and flow cytometry (p < 0.05). SiHa and SiHa-pc3 had no statistical significance (p > 0.05). Conclusions: The results showed that maspin gene can significantly inhibit human cervical SCC SiHa cell proliferation and effectively slow cancer growth. Maspin may be a new molecular target in the gene therapy of human cervical SCC.

Maspin; RT-PCR; Western blot; SiHa cell.

[1] Zou Z., Anisowicz A., Hendrix M.J., Thor A., Neveu M., Sheng S., et al.: “Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells”. Science, 1994, 263, 526.

[2] Machtens S., Serth J., Bokemeyer C., Bathke W., Minssen A., Koll-mannsberger C., et al.: “Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features”. Int. J. Cancer, 2001, 95, 337.

[3] Sheng S., Carey J., Seftor E.A., Dias L., Hendrix M.J., Sager R.: “Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells”. Proc. Natl. Acad. Sci. U. S. A., 1996, 93, 11669.

[4] Latha K., Zhang W., Cella N., Shi H.Y., Zhang M.: “Maspin medi-ates increased tumor cell apoptosis upon induction of the mitochon-drial permeability transition”. Mol. Cell. Biol., 2005, 25, 1737.

[5] Jiang N., Meng Y., Zhang S., Mensah-Osman E., Sheng S.: “Maspin sensitizes breast carcinoma cells to induced apoptosis”. Oncogene, 2002, 21, 4089.

[6] Bass R., Fernandez A.M., Ellis V.: “Maspin inhibits cell migration in the absence of protease inhibitor activity”. J. Biol. Chem., 2002, 277, 46845.

[7] Dokras A., Gardner L.M., Kirschmann D.A., Seftor E.A., Hendrix M.J.: “The tumor suppressor gene maspin is differentially regulated in cytotrophoblasts during human placental development”. Placenta, 2002, 23, 274.

MTT assay to human prostate cancer cell lines in vitro: establish-ment of test conditions and assessment of hormone-stimulated growth and drug- induced cytostatic and cytotoxic effects”. Prostate, 1988, 12, 99.

[9] Tahmatzopoulos A., Sheng S., Kyprianou N.: “Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis”. Oncogene, 2005, 24, 5375.

[10] Nam E., Park C.: “Maspin suppresses survival of lung cancer cells through modulation of Akt pathway”. Cancer Res. Treat., 2010, 42, 42.

[11] Kim M., Ju H., Lim B., Kang C.: “Maspin genetically and function-ally associates with gastric cancer by regulating cell cycle progres-sion”. Carcinogenesis, 2012, 33, 2344.

[12] Zhang W., Shi H.Y., Zhang M.: “Maspin overexpression modulates tumor cell apoptosis through the regulation of Bcl-2 family proteins”. BMC Cancer, 2005, 5, 50.

[13] Liu J., Yin S., Reddy N., Spencer C., Sheng S.: “Bax Mediates the apoptosis sensitizing effect of maspin”. Cancer Res., 2004, 64, 1703.

[14] Li X., Yin S., Meng Y., Sakr W., Sheng S.: “Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin”. Cancer Res., 2006, 66, 9323.

[15] Nakagawa M., Katakura H., Adachi M., Takenaka K., Yanagihara K., Otake Y., et al.: “Maspin expression and its clinical significance in non-small cell lung cancer”. Ann. Surg. Oncol., 2006, 13, 1517.

[16] Zou Z., Gao C., Nagaich A.K., Connell T., Saito S., Moul J.W., et al.: “p53 regulates the expression of the tumor suppressor gene maspin”. J. Biol. Chem., 2000, 275, 6051.

[17] Yasumatsu R., Nakashima T., Hirakawa N., Kumamoto Y., Kuratomi Y., Tomita K., Komiyama S.: “Maspin expression in stage I and II oral tongue squamous cell carcinoma”. Head Neck, 2001, 23, 962.

[18] Xia W., Lau Y.K., Hu M.C., Li L., Johnston D.A., Sheng S.J., et al.: “High tumoral maspin expression is associated with improved sur-vival of patients with oral squamous cell carcinoma”. Oncogene, 2000, 19, 2398.

[19] Liu H., Shi J., Anandan V., Wang H.L., Diehl D., Blansfield J., et al.: “Reevaluation and identification of the best immunohistochemical panel(pVHL,Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas”. Arch. Pathol. Lab. Med., 2012, 136, 601.

[20] Kim J., Jang K.T., Kim K.H., Park J.W., Chang B.J., Lee K.H., et al.: “Aberrant maspin expression is involved in early carcinogenesis of gallbladder cancer”. Tumor Biol., 2010, 31, 471.